1 |
2011-2012 seasonal flu vaccine intramuscular |
- |
- |
- |
- |
003 [2] 3 , 113 💬 |
2 |
2011-2012 seasonal flu vaccine subcutaneous |
- |
- |
- |
- |
003 [2] 3 , 113 💬 |
3 |
4-aminopyridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [2] 3 , 13 💬 |
4 |
4-cholesten-3-one, oxime |
- |
- |
- |
- |
002 [2] 2 , 3 💬 |
5 |
4-cholesten-3-one,oxime |
- |
- |
- |
- |
003 [1] 3 💬 |
6 |
Adipose derived mesenchymal stem cell |
- |
- |
- |
- |
003 [1] 3 💬 |
7 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
8 |
Amifampridine |
Amifampridine |
[1] D10228 D10228 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [3] 3 , 11, 12 💬 |
9 |
Amifampridine phosphate |
Amifampridine |
[1] D10228 D10228 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [3] 3 , 11, 12 💬 |
10 |
Amifampridine phosphate 10 mg oral tablet |
Amifampridine |
[1] D10228 D10228 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [1] 3 💬 |
11 |
Avxs-101 |
- |
- |
- |
- |
003 [1] 3 💬 |
12 |
Avxs-101 (previously known as scaav9.cb.smn) |
- |
- |
- |
- |
003 [1] 3 💬 |
13 |
Biocarn |
- |
- |
- |
- |
003 [1] 3 💬 |
14 |
Branaplam |
Branaplam |
- |
- |
- |
003 [1] 3 💬 |
15 |
Celecoxib |
Celecoxib |
[1] D00567 D00567 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 [9] 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
16 |
Gh |
- |
- |
- |
- |
003 [1] 3 💬 |
17 |
Human anti-promyostatin monoclonal antibody |
- |
- |
- |
- |
003 [1] 3 💬 |
18 |
Hydroxyurea |
Hydroxyurea |
[1] D00341 D00341 💬 |
RRM2 [1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
19 |
Isis 396443 |
- |
- |
- |
- |
003 [1] 3 💬 |
20 |
Isis 396443 (biib058) |
- |
- |
- |
- |
003 [1] 3 💬 |
21 |
Isis 396443, biib058 |
- |
- |
- |
- |
003 [1] 3 💬 |
22 |
Itraconazole |
Itraconazole |
[1] D00350 D00350 💬 |
- |
- |
003 [4] 3 , 65, 227, 299 💬 |
23 |
Leuprolide |
Leuprolide |
[2] D00989 D00989, D08113 D08113 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 [5] 1 , 2 , 3 , 51, 76 💬 |
24 |
Levocarnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 [3] 3 , 53, 97 💬 |
25 |
Lmi070 |
- |
- |
- |
- |
003 [1] 3 💬 |
26 |
Mestinon |
- |
- |
- |
- |
003 [3] 3 , 6 , 11 💬 |
27 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
28 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
29 |
Nerve growth factor |
Nerve Growth Factor |
- |
- |
- |
003 [2] 3 , 90 💬 |
30 |
Norditropin simplexx |
- |
- |
- |
- |
003 [4] 3 , 78, 193, 195 💬 |
31 |
Norditropin simplexx 15 mg/1.5 ml |
- |
- |
- |
- |
003 [1] 3 💬 |
32 |
Nursinersen |
- |
- |
- |
- |
003 [1] 3 💬 |
33 |
Nusinersen |
Nusinersen |
[1] D10881 D10881 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
34 |
Nusinersen injectable product |
Nusinersen |
[1] D10881 D10881 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
35 |
Nusinersen sodium |
Nusinersen |
[1] D10881 D10881 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
36 |
Nusinersen treatments |
Nusinersen |
[1] D10881 D10881 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
37 |
Olesoxime |
- |
- |
- |
- |
002 [2] 2 , 3 💬 |
38 |
Onasemnogene abeparvovec |
Onasemnogene abeparvovec |
[1] D11559 D11559 💬 |
SMN1 [1] SMN1 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
39 |
Onasemnogene abeparvovec-xioi |
Onasemnogene abeparvovec |
[1] D11559 D11559 💬 |
SMN1 [1] SMN1 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
40 |
Orfiril saft |
- |
- |
- |
- |
003 [1] 3 💬 |
41 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 [1] 3 💬 |
42 |
Other: prospective observational registry |
- |
- |
- |
- |
003 [1] 3 💬 |
43 |
Paracetamol |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [5] 3 , 6 , 13, 35, 46 💬 |
44 |
Paracetamol 120mg/5ml oral suspension |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [1] 3 💬 |
45 |
Phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [11] 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
46 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
47 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
48 |
Procedure: air stacking manuever |
- |
- |
- |
- |
003 [1] 3 💬 |
49 |
Procedure: sham procedure |
- |
- |
- |
- |
003 [1] 3 💬 |
50 |
Pyridostigmine |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [4] 3 , 6 , 11, 256 💬 |
51 |
Pyridostigmine bromide |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [3] 3 , 6 , 256 💬 |
52 |
Reldesemtiv |
Reldesemtiv |
[1] D11363 D11363 💬 |
TNNC2 [1] TNNC2 💬 |
Calcium signaling pathway [1] Calcium signaling pathway |
002 [2] 2 , 3 💬 |
53 |
Reldesemtiv 150 mg |
Reldesemtiv |
[1] D11363 D11363 💬 |
TNNC2 [1] TNNC2 💬 |
Calcium signaling pathway [1] Calcium signaling pathway |
003 [1] 3 💬 |
54 |
Reldesemtiv 450 mg |
Reldesemtiv |
[1] D11363 D11363 💬 |
TNNC2 [1] TNNC2 💬 |
Calcium signaling pathway [1] Calcium signaling pathway |
003 [1] 3 💬 |
55 |
Riluzole |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [8] 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
56 |
Risdiplam |
Risdiplam |
[1] D11406 D11406 💬 |
SMN2 [1] SMN2 💬 |
RNA transport [1] RNA transport |
003 [1] 3 💬 |
57 |
Ro6885247 |
- |
- |
- |
- |
003 [1] 3 💬 |
58 |
Ro6885247/f02 |
- |
- |
- |
- |
003 [1] 3 💬 |
59 |
Ro6885247/f03 |
- |
- |
- |
- |
003 [1] 3 💬 |
60 |
Ro7034067 |
- |
- |
- |
- |
003 [1] 3 💬 |
61 |
Ro7034067 / f12 |
- |
- |
- |
- |
003 [1] 3 💬 |
62 |
Ro7034067 / f13 |
- |
- |
- |
- |
003 [1] 3 💬 |
63 |
Ro7034067/f06 + solvente (ro |
- |
- |
- |
- |
003 [1] 3 💬 |
64 |
Ro7034067/f06 with solvent (ro7034067/f08) |
- |
- |
- |
- |
003 [1] 3 💬 |
65 |
Ro7034067/f07 + solvente (ro |
- |
- |
- |
- |
003 [1] 3 💬 |
66 |
Ro7034067/f07 with solvent (ro7034067/f09) |
- |
- |
- |
- |
003 [1] 3 💬 |
67 |
Ro7034067/f12 |
- |
- |
- |
- |
003 [1] 3 💬 |
68 |
Ro7034067/f13 |
- |
- |
- |
- |
003 [1] 3 💬 |
69 |
Ro7090919 |
- |
- |
- |
- |
003 [1] 3 💬 |
70 |
Rvg 03820 |
- |
- |
- |
- |
003 [1] 3 💬 |
71 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
72 |
Sesame oil |
Sesame oil |
[1] D03314 D03314 💬 |
- |
- |
003 [1] 3 💬 |
73 |
Sesame oil, refined |
Sesame oil |
[1] D03314 D03314 💬 |
- |
- |
003 [1] 3 💬 |
74 |
Smart |
- |
- |
- |
- |
003 [1] 3 💬 |
75 |
Sodium phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [4] 2 , 3 , 8 , 251 💬 |
76 |
Sodium phenylbutyrate (napb) |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
003 [1] 3 💬 |
77 |
Somatotropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
003 [3] 3 , 78, 236 💬 |
78 |
Somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [16] 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
79 |
Spinraza |
- |
- |
- |
- |
003 [1] 3 💬 |
80 |
Srk-015 |
- |
- |
- |
- |
003 [1] 3 💬 |
81 |
Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide |
- |
- |
- |
- |
003 [1] 3 💬 |
82 |
Testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 [8] 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
83 |
Tro19622 |
TRO19622 |
- |
- |
- |
002 [3] 2 , 3 , 13 💬 |
84 |
Valproate |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 [6] 2 , 3 , 90, 102, 233, 256 💬 |
85 |
Valproate sodium |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
86 |
Valproate, levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
87 |
Valproic acid |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [10] 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
88 |
Valproic acid (vpa) |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
89 |
Valproic acid and levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
90 |
Volmax*30cpr 4mg r.p. |
- |
- |
- |
- |
003 [1] 3 💬 |
91 |
Vpa |
- |
- |
- |
- |
003 [1] 3 💬 |
92 |
Zolgensma |
- |
- |
- |
- |
003 [1] 3 💬 |